Abbott’s Humira discount
Executive Summary
The average sales price of Abbott's rheumatoid arthritis treatment Humira (adalimumab) is about 8% below its listed wholesale acquisition cost, Centers for Medicare & Medicaid Services data indicates. The Humira wholesale acquisition cost is $605.39 per 40 mg dose, according to Red Book. The average sales price of $555.91 per 40 mg is based on CMS' published second quarter Medicare Part B payment limit. Although the product is not reimbursed under Part B, average sales price data is reported for adalimumab because it is assigned a J-code, Abbott said...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.